Skip to contentC
Chemed Corp
C
CHEChemed Corp Q2 2017 · 10-Q
Revenue$415.06M$415.06M+6.3% vs Q2 2016 Net Income-$21.66M-$21.66MN/M vs Q2 2016 EPS Diluted-$1.35-$1.35N/M vs Q2 2016 Operating Income-$38,948,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$12,425,000−78.5% Margins · derivedOperating margin-9.4%−19.2 pt vs Q2 2016
Net margin-5.2%−11.6 pt vs Q2 2016
ended Jun 30, 2017 · filed Jul 31, 2017 · 31 d after period end